Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RXL vs. JDOC: which is better?

Bottom line

RXL vs JDOC: the short answer

RXL (ProShares Ultra Health Care) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 51% by weight.

JDOC is cheaper at 0.65% vs 0.95% — a difference of $30 a year per $10,000 invested.

Over one year, RXL returned +19.7% vs +14.9% for JDOC.

Updated Nov 19, 2026

RXL vs JDOC side by side

RXLJDOC
TypeETFETF
Fund familyProSharesJ.P. Morgan
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.95%0.65%
Annual cost per $10k$95$65
10-yr cost on $10k (prospectus)$1,305$810
Max front loadNoneNone
12b-1 fee——
1-yr return+19.7%+14.9%
5-yr return (annualized)+7.2%—
10-yr return (annualized)+12.6%—
Best quarter+29.7%+11.3%
Worst quarter−28.9%−11.9%
Net assets (fund)$72.1M$9.1M
Number of holdings7061
Portfolio turnover4%92%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRXLJDOCDifference
2025+19.7%+14.9%+4.7%
2024−2.7%−0.6%−2.0%

Source: Fund prospectus bar charts

Holdings overlap

12 of RXL's top 25 holdings also appear in JDOC's top 25.

Shared top holdings
HoldingRXLJDOC
Eli Lilly & Co.12.67%7.76%
Johnson & Johnson7.86%4.82%
AbbVie, Inc.5.57%7.85%
UnitedHealth Group, Inc.4.98%5.85%
Merck & Co., Inc.4.26%4.82%
Thermo Fisher Scientific, Inc.2.68%3.73%
Intuitive Surgical, Inc.2.18%1.93%
Abbott Laboratories2.15%3.11%
Bristol-Myers Squibb Co.1.68%3.57%
CVS Health Corp.1.67%2.83%
Danaher Corp.1.66%2.16%
Stryker Corp.1.52%2.23%

Source: SEC Form N-PORT

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

FAQ

What is the difference between RXL and JDOC?
RXL (ProShares Ultra Health Care) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 51% by weight. JDOC is cheaper at 0.65% vs 0.95% — a difference of $30 a year per $10,000 invested.
Which is cheaper, RXL or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both RXL and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.